Bayer A.G.Bayer A.G.Bayer A.G.

Bayer A.G.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪31.78 B‬USD
−0.97USD
‪−2.76 B‬USD
‪50.41 B‬USD
‪3.93 B‬
Beta (1Y)
0.49

About Bayer AG


CEO
William N. Anderson
Website
Headquarters
Leverkusen
Founded
1952
ISIN
US0727303028
FIGI
BBG000BYMB76
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Check out other big names from the same industry as BAYRY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BAYZ5705352
Bayer US Finance LLC 6.375% 21-NOV-2030
Yield to maturity
Maturity date
Nov 21, 2030
MON.GD
Monsanto Finance Canada Co. 5.5% 30-JUL-2035
Yield to maturity
Maturity date
Jul 30, 2035
BAYZ3666848
Monsanto Company 5.5% 30-JUL-2035
Yield to maturity
Maturity date
Jul 30, 2035
BAYZ4790623
Bayer US Finance II LLC 5.875% 15-APR-2038
Yield to maturity
Maturity date
Apr 15, 2038
BAYZ5705354
Bayer US Finance LLC 6.5% 21-NOV-2033
Yield to maturity
Maturity date
Nov 21, 2033
BAYZ4660477
Bayer US Finance II LLC 4.2% 15-JUL-2034
Yield to maturity
Maturity date
Jul 15, 2034
BAYZ4140707
Monsanto Company 4.4% 15-JUL-2044
Yield to maturity
Maturity date
Jul 15, 2044
BAYZ4663164
Bayer US Finance II LLC 4.7% 15-JUL-2064
Yield to maturity
Maturity date
Jul 15, 2064
BAYZ5705356
Bayer US Finance LLC 6.875% 21-NOV-2053
Yield to maturity
Maturity date
Nov 21, 2053
BAYZ4230946
Monsanto Company 3.95% 15-APR-2045
Yield to maturity
Maturity date
Apr 15, 2045
BAYZ4841297
Bayer US Finance II LLC 5.5% 30-JUL-2035
Yield to maturity
Maturity date
Jul 30, 2035

See all BAYRY bonds 

Curated watchlists where BAYRY is featured.